礼来(LLY.N)盘前上涨2.2%，此前Hims & Hers撤回了减肥药的上市计划。

Core Viewpoint - Eli Lilly (LLY.N) shares rose by 2.2% in pre-market trading following Hims & Hers' withdrawal of its weight loss drug launch plan [1] Group 1 - Eli Lilly's stock performance indicates a positive market reaction to the news regarding Hims & Hers [1] - The withdrawal of Hims & Hers' weight loss drug may create a more favorable competitive landscape for Eli Lilly in the weight loss pharmaceutical market [1]